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O B J E C T I V E S The aim of this study was to evaluate whether, in patients with evidence of both
electrical and mechanical left ventricular (LV) dyssynchrony, extensive LV dilation would affect response
to cardiac resynchronization therapy (CRT).
B A C KG ROUND Cardiac resynchronization therapy is effective in heart failure patients with LV
dysfunction and wide QRS complex. However, many patients still fail to respond. We hypothesized that
presence of extensive LV dilation might prevent response to CRT, despite LV mechanical dyssynchrony.
METHOD S We studied 78 heart failure patients (68  9 years of age, 77% men) with both electrical
(QRS width 120 ms) and mechanical intraventricular dyssynchrony (by tissue Doppler imaging and/or
left lateral wall post-systolic contraction). Echocardiographic evaluation was performed at baseline and
6 to 8 months after CRT. As an indication of LV remodeling, end-diastolic volume index and end-systolic
volume index (ESVI) and sphericity index were measured. Long-term (40 23 months) clinical follow-up
(events: cardiac death and hospital admission for heart failure) was also obtained.
R E S U L T S At follow-up after CRT, in the overall population, ejection fraction increased from 26 6%
to 35  11% (p  0.0001), whereas end-diastolic volume index (from 144  43 ml/m2 to 119  55
ml/m2), ESVI (from 108  37 ml/m2 to 82  49 ml/m2, p  0.0001 for both), and sphericity index (from
0.60  0.22 to 0.53  0.15, p  0.0036) all signiﬁcantly decreased. By multiple linear regression analysis,
after controlling for confounding factors, change in LV ejection fraction at follow-up resulted
independently and negatively associated with baseline ESVI (p  0.001), with much lower improvement
after implant in the highest tertile of baseline ESVI. During follow-up, 31 patients (39.7%) had a cardiac
event. By Cox regression model, baseline ESVI was the most powerful predictor of events, with
event-rate/year increasing with increasing tertiles of ESVI (6.3%, 10.1%, and 23.8%, respectively, p 
0.05).
CONC L U S I O N S In this nonrandomized, open-label clinical study, despite intraventricular electri-
cal and mechanical dyssynchrony, extensive LV remodeling at baseline negatively impacted CRT results
in terms of LV function improvement and incidence of cardiac events at follow-up. (J Am Coll Cardiol
Img 2011;4:1067–76) © 2011 by the American College of Cardiology Foundation
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1068n symptomatic, optimally treated heart failure
(HF) patients with 35% left ventricular ejection
fraction (LVEF) and wide QRS, cardiac resyn-
chronization therapy (CRT) by biventricular pac-
ing significantly reduces morbidity and mortality,
and it improves quality of life, functional class, and
exercise capacity (1,2). Therefore, CRT has become
See page 1077
established treatment for patients with symptomatic
HF and systolic dysfunction in whom dyssynchrony
is present, as denoted by 120-ms QRS duration
(3,4). However, response in terms of clin-
ical benefits and left ventricular (LV) re-
verse remodeling is heterogeneous and
often unpredictable, because many such
patients fail to respond to CRT (1,2,4,5).
Reasons for lack of response to CRT
are not fully understood. For one thing,
a wide QRS (i.e., electrical dyssyn-
chrony) does not necessarily equate to
mechanical dyssynchrony (6). Therefore,
direct assessment of mechanical dyssyn-
chrony by echocardiography has been pro-
posed to select CRT candidates (6–9).
However, even patients with ascertained
mechanical dyssynchrony might fail to
respond (10). Association between in-
creased LV diameters at baseline and poor
outcome after CRT implant has been
described in some (11,12) but not all
studies (13). Inherent limitations of LV
diameters as a measure of LV remodeling
might explain shortcomings of diameter
measurements in predicting outcome after
CRT (11–13). In fact, although LV diam-
eter measurements by M-mode echocardi-
ography allow acceptable estimation of
LVEF and correlate with LV volumes,
they are hindered by a wide margin of error when
it comes to accurate LV size assessment, espe-
cially for enlarged ventricles (14). Therefore,
little and conflicting information is currently
available on this issue. In particular, the relation-
ship between extent of baseline LV remodeling,
degree of intraventricular mechanical dyssynchrony, and
improvement of LV function at follow-up is not well-
known.
We sought to investigate whether, in patients
with evidence of both electrical and mechanical LV
dyssynchrony, extensive LV dilation would affect
tion
e
ar
g
et
ysuccessful response to CRT in terms of improve- wment in LVEF and of occurrence of cardiac events
at follow-up.
M E T H O D S
Patient population. From August 2003 to June
2010, in 158 patients who underwent CRT at our
institution according to guideline recommenda-
tions, complete echocardiographic evaluation was
also performed before device implant. Of these, we
enrolled patients who also met the following crite-
ria: 1) chronic LV systolic dysfunction (ejection
fraction [EF]35%); 2) optimal medical treatment
for HF since 2 months; 3) QRS duration 120
ms; and 4) mechanical dyssynchrony (see the As-
sessment of Intraventricular Dyssynchrony section).
In addition, exclusion criteria were: atrial fibrilla-
tion, recent (6 months) myocardial infarction
and/or coronary revascularization, poor echocardio-
graphic window, hemodynamic instability, and life
expectancy of 1 year due to noncardiac diseases.
Study protocol. Baseline evaluation included clinical
ariables, New York Heart Association (NYHA)
unctional class, electrocardiogram, and 2-dimensional
chocardiography. Implant of CRT device occurred
ithin 1 month of baseline evaluation. Patients
ere then scheduled for follow-up (1 week, 1 and 6
onths); at each follow-up visit, CRT device was
nterrogated to ensure that biventricular pacing was
aintained. Within 1 month after CRT implant,
V diastolic filling time was optimized. Six to 8
onths after CRT implant, 2-dimensional echo-
ardiography was repeated to assess LVEF and
olumes. Clinical follow-up was then continued for
0  23 months after implant. An absolute LVEF
mprovement 5% was considered clinically signif-
cant (15). The protocol was approved by our ethics
ommittee, and all patients gave written informed
onsent.
Device implantation. The LV pacing leads were
mplanted transvenously typically through a single
eft chest incision, left cephalic vein cutdown, and
eft subclavian puncture. Transvenous implantation
f the device was successful in all patients but 1,
ho had the LV lead surgically implanted. The LV
acing lead was placed in a tributary of the coronary
inus. A posterolateral branch was used in 68% of
atients; a lateral branch was used in the remainder.
he LV lead position was assessed by chest x-ray in
rontal and lateral views. Optimal atrioventricular
elay was determined by pulsed-wave Doppler of
V inflow, selecting the optimal atrioventricular
elay associated with the longest LV filling timeA B B R E V I A T I O N S
A N D A C R O N YM S
CRT cardiac resynchroniza
therapy
EDVI end-diastolic volum
index
EF ejection fraction
ESVI end-systolic volume
ndex
F heart failure
interVD interventricular
dyssynchrony
intraVD intraventricular
dyssynchrony
LV left ventricle/ventricul
LVEF left ventricular
ejection fraction
LWPSC left wall
post-systolic contraction
NYHA New York
Heart Association
TDI tissue Doppler imagin
TsO interval from the ons
of QRS to the onset of
systolic velocityithout interrupting the A-wave (16).
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1069Echocardiography. Echocardiographic examinations
ere performed with GE Vivid 7 (GE Healthcare,
halfont St. Giles, United Kingdom), equipped
ith a transducer employing harmonic imaging.
xams were obtained in digital format and stored
n compact disc/digital video disc for offline anal-
sis. Patients were studied in left-lateral decubitus.
he LV end-diastolic and end-systolic volumes,
F, and left atrial end-systolic volume were calcu-
ated by a modified Simpson biplane method from
pical imaging planes (17). The LV mass was
alculated by the area–length formula (17). The LV
ransverse diameter at end-systole was calculated
rom LV short-axis area at papillary muscle level as:
V diameter 2 2 (LV area/3.14)0.5. Severity
of mitral regurgitation (grades I to IV) was deter-
mined according to American Society of Echocar-
diography guidelines (17,18). All cardiac chamber
volumes and mass measures were indexed to body
surface area. Global geometry was evaluated by
calculating the sphericity index (19,20).
Assessment of intraventricular dyssynchrony. Intra-
ventricular dyssynchrony (intraVD) was assessed by
the following:
1. Spectral displays with pulsed-wave tissue
Doppler imaging (TDI), obtained by placing a
3-mm sample volume in the middle of each of
the 6 basal LV segments in 4-, 3-, and
2-chamber apical views (21). Gain and filter
settings were adjusted to minimize background
noise and to allow for a clear spectral display.
Figure 1. Measurement of Intraventricular Dyssynchrony and o
Measurement of intraventricular dyssynchrony by tissue Doppler imag
[LWPSC], B). Simultaneous display of electrocardiogram, left ventricular
tion of lateral wall after aortic valve closure, whereas diastolic overlap idenCare was taken to keep the incident angle
between direction of Doppler beam and the
analyzed vector of myocardial motion as small
as possible. Measurements were performed at
100 mm/s sweep. Three end-expiratory beats
were averaged. The interval from the onset of
QRS to the onset of systolic velocity (TsO) in
each explored segment, a surrogate for regional
electromechanical coupling interval (Fig. 1A),
was measured (21). Intraobserver and interob-
server variabilities for TsO were 5.2 2.4% and
6.4  2.8%, respectively. IntraVD was consid-
ered in the presence of an absolute difference
(Delta-TsO)65 ms between the longest and the
shortest TsO in the 6 LV basal segments (21).
2. Post-systolic contraction of left lateral wall
(LWPSC), recorded in the 4-chamber apical
view with color M-mode TDI after aortic valve
closure. When LWPSC persisted beyond the
onset of the next filling phase (measured from
QRS onset to the beginning of E-wave at
pulsed-wave Doppler of mitral inflow), the
overlap of LWPSC contraction and ventricular
filling was measured (22). Diastolic contraction
and overlap identify presence of LV segments
not temporally synchronized within the cardiac
cycle. Any positive LWPSC was considered as a
sign of dyssynchrony (22) (Fig. 1B).
3. Finally, interventricular dyssynchrony (interVD) was
calculated as the difference between TsO in the
basal lateral segment of right ventricle and in
the most delayed LV segment. A sum dyssyn-
stolic Overlap
A), and of diastolic overlap (left wall post-systolic contraction
g and left lateral wall contraction is shown: LWPSC is the contrac-f Dia
ing (
ﬁllintiﬁes persistence of contraction after mitral valve opening.
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1070chrony (sumVD) was then calculated by adding
intraVD and interVD, and a value 140 ms
was considered significant.
atients needed to fulfill 1 of the aforementioned
riteria of mechanical dyssynchrony to be included
n the study.
Long-term follow-up. Long-term follow-up was per-
formed by chart review, clinical exam at our outpa-
tient HF clinic, and telephone contacts. Events
included death and hospital admission for HF.
Statistical analysis. Continuous data are presented as
ean  SD, and categorical data are presented as
requencies and percentages. The NYHA func-
ional class is presented as median  interquartile
ange. Two-sided paired and unpaired Student t
est were used for normally distributed variables,
hereas Mann-Whitney U test or Wilcoxon
igned-rank test were used for non-normally dis-
ributed variables. Pearson correlation coefficient
as used when appropriate. Chi-square test (with
isher exact test when appropriate) was used to
ompare categorical variables in 2  2 contingency
ables. Linear regression analysis was performed to
ssess univariate relationships between change of
VEF at follow-up and continuous clinical and
chocardiographic variables. Stepwise multivariable
inear regression analysis was then used to deter-
ine which of the important univariate variables
ere significant independent predictors of LVEF
mprovement. Collinearity diagnostic procedure
as performed first by examining the correlation
etween independent variables to detect a high level
f association. If high bivariate correlation (0.50)
as present between 2 variables, the variable that
as a stronger predictor in univariable unadjusted
nalysis was chosen and the other eliminated.
Differences in cardiac event rates over time were
nalyzed by the Kaplan-Meier method and log-
ank test. The effect of different variables on event-
ree survival was investigated with Cox proportional
azards model. Variables that showed a significant
ffect on survival in univariable analyses (p  0.1)
ere entered in a multivariable Cox proportional
azards model with backward stepwise selection to
btain the final model. At each step, the least
ignificant variable was discarded from the model,
ntil all variables in the model reached a p value
0.10. The number of variables that could enter
he multivariate was limited with the pm/10 rule
o prevent over-fitting the model. All p values were
-sided; a p value0.05 was considered statistically
ignificant. Analyses were performed with STATAoftware version 9, (StataCorp, College Station,
exas) and SAS (Chicago, Illinois).
R E S U L T S
From an initial population of 95 patients fulfilling all
enrolment criteria, 4 were subsequently excluded for
failure of device implant, 4 patients died before echo-
cardiographic follow-up, and 6 patients were lost to
follow-up; whereas in 3 patients LV pacing was
switched off due to phrenic nerve stimulation.
Seventy-eight patients represent the final population.
Of these, 44 (56%) received a CRT with biventricular
pacing-only device, and 34 (44%) received a CRT
with a biventricular implantable cardioverter defibril-
lator device. Table 1 summarizes baseline characteris-
tics of the population; mean age was 69  9 years;
67% of patients had nonischemic etiology of HF.
IntraVD by TDI was 77 29 ms at baseline, and
it was 65 ms in 54 (69%) patients. InterVD by
TDI was 82 50 ms at baseline, whereas a sumVD
140 ms was found in 47 (60%) patients (Table 2).
LWPSC 40 ms was found in 51 (65%) pa-
ients, and 52 (67%) patients showed a positivity of
2 dyssynchrony parameters.
Response to cardiac resynchronization. In the whole
population, NYHA functional class improved at
follow-up from a median 3 (interquartile range 2 to
4) to 1 (interquartile range: 1 to 2) (p  0.0001),
and prevalence of patients in NYHA functional
class III/IV decreased from 72% to 21% (p 0.01).
The EF also significantly improved, from 26  6% to
35  11% (p  0.0001); significant reduction in
end-diastolic volume index (EDVI) (144  43
ml/m2 to 119  55 ml/m2; p  0.0001), ESVI
108  37 ml/m2 to 82  49 ml/m2; p  0.0001),
and sphericity index (0.60  0.22 to 0.53  0.15,
p  0.0036) was also observed.
Parallel to improvement in LV remodeling pa-
rameters, mitral regurgitation severity also signifi-
cantly improved at follow-up, because the propor-
tion of patients with significant mitral regurgitation
(defined as effective regurgitant orifice area 0.2
cm2) decreased from 39% to 21% (p  0.05).
LV remodeling and EF improvement after CRT. Linear
regression analysis was performed to define the
strength of association between EF improvement at
follow-up and clinical and echocardiographic vari-
ables of LV remodeling and mechanical dyssyn-
chrony (Table 2). Percentage increase in EF was
associated with QRS duration (p  0.007), LV
diastolic and systolic diameters (p  0.004 for
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1071both), EDVI (p  0.0001), ESVI (p  0.003), left
trial volume index (p  0.037), intraVD by TDI
p  0.001), and sumVD by TDI (p  0.027).
urthermore, patients with 2 dyssynchrony pa-
ameters at baseline showed greater increase in
VEF (10  9% vs. 6  9%, p  0.05) than
atients in whom only 1 parameter of mechanical
yssynchrony was altered. Age and blood pressure
howed no correlation with LVEF improvement.
A multivariable linear regression analysis was
hen constructed specifically to determine which of
hese variables were independent predictors of
VEF improvement. Baseline EDVI and LV sys-
olic diameter showed high collinearity and there-
Table 1. Characteristics of Study Population (n  78)
Age (yrs) 68 8
Male 60 (77)
BSA (kg/m2) 1.86 0.21
Heart rate (beats/min) 70 11
Systolic BP (mm Hg) 116 13
Diastolic BP (mm Hg) 70 9
NYHA functional class 3 to 4 56 (72)
QRS duration (ms) 165 30
LBBB 57 (73)
Etiology of heart failure
Ischemic 26 (33)
Nonischemic 52 (67)
Medications
ACEI/ARB 66 (85)
Diuretics 69 (89)
Beta-blockers 59 (76)
Nitrates 35 (45)
Aldosterone antagonists 49 (63)
Echocardiography
LV internal diastolic diameter (cm) 7.63 0.88
EDVI (ml/m2) 144 43
ESVI (ml/m2) 108 37
Ejection fraction (%) 26 6
Left atrial volume index (ml/m2) 44 20
Mitral regurgitation severity (EROA 0.2 cm2) 31 (39)
Sphericity index 0.62 0.23
IntraVD by TDI (ms) 77 29
InterVD (ms) 82 49
SumVD (ms) 159 71
LWPSC (ms) 69 87
Values are mean  SD or n (%).
ACEI  angiotensin-converting enzyme inhibitor; ARB  angiotensin
receptor blocker; BP  blood pressure; BSA  body surface area; EDVI 
end-diastolic volume index; EROA  effective regurgitant oriﬁce area; ESVI 
end-systolic volume index; interVD  interventricular dyssynchrony;
intraVD  intraventricular dyssynchrony; IQR  interquartile range; LBBB 
left bundle branch block; LV left ventricular; LWPSC left wall post-systolic
contraction; NYHA  New York Heart Association; sumVD  sum dyssyn-
chrony; TDI  tissue Doppler imaging.ore were not included in the final model. Bothaseline ESVI and intraVD by TDI were found to
e significant and independent predictors of EF
mprovement (p  0.001 and p  0.0001, respec-
ively), whereas the association of LV diastolic
iameter with EF improvement became insignifi-
ant (p  NS). Improvement in EF was lowest in
he highest tertile of baseline ESVI and greatest in
he lowest tertile (i.e., smaller LV volume) (Fig. 2).
igure 3 shows the interrelations between baseline
SVI, intraVD, and improvement in EF after
RT; patients with low ESVI (103 ml/m2, me-
dian value) and 2 parameters of IntraVD at base-
line had the greatest increase in EF at follow-up,
whereas patients with high ESVI (103 ml/m2) and
only 1 parameter of intraVD at baseline showed no
significant improvement in EF after CRT.
LV dyssynchrony, remodeling, and prognosis. During
a mean follow-up of 40  23 months, an event of
the composite endpoint (death/hospital admission
for HF) occurred in 31 (40%) patients. At the end
of follow-up, 16 patients (21%) had died, and there
had been 25 (32%) repeat hospital admissions for
HF. Table 3 shows clinical and echocardiographic
characteristics of patients according to whether or
not they developed an event during follow-up.
Table 2. Univariate Correlates of EF Improvement
Univariate Analysis
Beta p Value
Age (yrs) 0.15 0.194
BSA (kg/m2) 0.06 0.557
Heart rate (beats/min) 0.20 0.075
Systolic BP (mm Hg) 0.10 0.335
Diastolic BP (mm Hg) 0.14 0.223
QRS duration (ms) 0.30 0.007
LV internal diastolic diameter (cm) 0.32 0.004
LV internal systolic diameter (cm) 0.32 0.004
EDVI (ml/m2) 0.41 0.0001
ESVI (ml/m2) 0.34 0.003
Ejection fraction (%) 0.07 0.514
Left atrial volume index (ml/m2) 0.24 0.037
Mitral regurgitation severity (grade) 0.11 0.336
LV mass index (g/m2) 0.16 0.148
Sphericity index 0.09 0.392
InterVD by TDI (ms) 0.14 0.218
IntraVD by TDI (ms) 0.37 0.001
SumVD (ms) 0.25 0.027
LWPSC (ms) 0.07 0.536
Combined IntraVD (2 parameters) 0.23 0.042
LV lead position 0.05 0.680EF  ejection fraction; other abbreviations as in Table 1.
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1072Compared with patients without events, patients
with events showed lower systolic and diastolic
blood pressure (p  0.05 for both) and significantly
higher EDVI, ESVI (p  0.05 for both), and
Relationship Between Baseline ESVI and Changes
r CRT Implant
of improvement in ejection fraction (EF) was lowest in the high-
of baseline end-systolic volume index (ESVI) and highest in the
ile. CRT  cardiac resynchronization therapy.
Relationship Between Baseline ESVI, intraVD, and
ent in EF After CRT
EF at follow-up was greater in patients with lower ESVI (103
d 2 positive parameters of intraventricular dyssynchrony
t baseline, whereas patients with higher ESVI (103 ml/m2) and
ameter of intraVD at baseline showed no signiﬁcant improvement
CRT. Intermediate levels of improvement in EF were observed in
ith higher ESVI at baseline but combined intraVD as well as in
ith lower ESVI and only 1 parameter of intraVD. Abbreviations as
.sphericity index (p  0.013). Age, sex, dyssyn-
chrony indexes, and QRS width did not signifi-
cantly differ between the 2 groups.
By Cox proportional hazard model, after correct-
ing for these confounding factors (Table 2), ESVI
103 ml/m2 (median value) (hazard ratio: 2.53,
5% confidence interval: 1.17 to 5.44, p  0.017)
nd low systolic blood pressure (hazard ratio: 0.95,
5% confidence interval: 0.93 to 0.99, p  0.006)
ere the most powerful predictors of cardiac events.
igure 4A shows that incidence of events/year in-
reased with increasing tertiles of baseline ESVI (p
.01) and that event-free survival was markedly lower
n the higher tertile of baseline ESVI (Fig. 4B).
D I S C U S S I O N
The present study shows that, in HF patients with
dyssynchrony documented by both electrical and
mechanical criteria, resynchronization therapy
might not be effective if extensive LV remodeling is
present at the time of implant. Specifically, im-
provement in EF was inversely related to baseline
ESVI. Moreover, long-term survival free of cardiac
death/repeat hospital admission for HF was signif-
icantly better in the presence of smaller ESVI.
Although precise definition of what constitutes
good CRT response is still controversial (10,23),
failure of dyssynchronous myocardium to improve
after CRT in many patients is a major limitation of
this therapy. To increase the sensitivity, a composite
definition of response has been proposed, which
includes both clinical and functional measures (10).
Because agreement between different methods to
define response to CRT is poor (23), we avoided
categorizing patients into responders or nonre-
sponders. Therefore, we explored the relationship
between degree of baseline LV remodeling and
increase in EF at follow-up as a continuous variable.
Furthermore, to circumvent limitations of NYHA
functional class and/or quality of life measurement to
assess the clinical benefit of CRT, we reported the
incidence of hard endpoints, namely death and repeat
hospital admission for HF.
Failure to improve after CRT has been related to
various issues, including baseline altered LV dimen-
sions. However, with respect to this latter mecha-
nism, data are not conclusive. In 1 study (13),
baseline LV end-diastolic diameter showed a posi-
tive correlation with echocardiographic endpoints at
follow-up. Conversely, Diaz-Infante et al. (11)
reported that large LV end-diastolic diameter (75Figure 2.
in EF Afte
Likelihood
est tertileFigure 3.
Improvem
Increase in
ml/m2) an
(intraVD) a
only 1 par
in EF after
patients w
patients wmm) was an independent predictor of lack of
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1073response to CRT; in that study, however, neither
LV volumes nor mechanical dyssynchrony were
assessed at baseline. More recently, in patients with
chronic HF in whom CRT was performed only if
mechanical dyssynchrony was documented, Gradaus
et al. (12) found that increased LV end-systolic
diameter and concomitant diastolic dysfunction
were associated with significantly worse outcome.
However, both latter studies employed LV diam-
eters as an estimate of LV remodeling; as already
mentioned, LV diameters might have substantial
shortcomings as a measure of LV remodeling
(11–13).
In the present study we performed a comprehen-
sive assessment of LV remodeling, including mea-
surements of baseline end-diastolic and end-systolic
volumes, LV mass, and sphericity index (24,25).
Thus, our study provides new information showing
that extensive LV remodeling at baseline is associ-
ated with poor functional improvement at follow-
up, with minimal changes in EF in the higher
tertile of baseline ESVI. When we evaluated the
relationship between intraVD, LV systolic dysfunc-
tion, baseline LV remodeling, and extent of func-
tional improvement after CRT, severity of intraVD
and low ESVI significantly predicted improvement
in EF after CRT (Table 3), whereas LV diameters
did not enter the equation. Interestingly, the great-
est improvement in EF was seen in patients with
the most dyssynchronous myocardium (2 param-
eters of intraVD) and smaller LV (ESVI 103
ml/m2), whereas patients with extensive remodeling
(ESVI 103 ml/m2) and only 1 parameter of
intraVD at baseline showed no significant changes
in EF after CRT (Fig. 4). Therefore, patients with
low likelihood to improve in LV function after
CRT were more likely to be those with larger LVs.
Another finding of our study is that large ESVI
at the time of implant was also an independent and
strong predictor of poor outcome during long-term
follow-up. Rate of cardiac events significantly in-
creased with increasing tertiles of baseline ESVI;
Kaplan-Meier analysis showed significantly lowest
event-free survival in the highest tertile of ESVI.
These findings are consistent with earlier observa-
tions that LV end-systolic volume is an indepen-
dent strong predictor of long-term prognosis in the
general population of HF patients (26) and in
patients undergoing CRT (27). In a single-center
registry of HF patients treated with CRT, assess-
ment of the influence of pre-implant characteristics
on long-term outcome has shown that large LV
end-systolic volume was significantly and indepen-dently associated with poor prognosis after implant
(27). Furthermore, increased end-systolic volume
limits improvement in LVEF after revascularization
in patients with chronic ischemic cardiomyopathy,
despite presence of viability (28). Overall, these
observations lend credence to the hypothesis that
extensively remodeled ventricles might be beyond
recovery (29), even in the presence of an amendable
substrate, such as asynchrony (as in the present
study) or myocardial hibernation (28).
Having selected patients on the basis of the
presence of intraVD, we obviously did not find
differences in each single parameter of asynchrony
between patients who developed events compared
with those who did not develop events during
long-term follow-up. However, patients who had a
combination of 2 dyssynchrony parameters
showed a greater increase in EF at follow-up than
patients with just 1 parameter of dyssynchrony.
Because no single parameter will completely dictate
CRT response (23), this might highlight the con-
cept that combining different methods or using
scoring systems might be a better approach to select
responders. In the study by Gorcsan et al. (30),
combination of longitudinal and radial measures by
speckle tracking predicted EF response significantly
better than either technique alone. Recently, Lafitte
et al. (31) demonstrated that use of a multiparamet-
Table 3. Characteristics of Study Population Grouped According
Presence or Absence of Cardiac Events
Events (n  31) No Events (n 
Age (yrs) 70 7 67 9
Male (%) 25 (81) 35 (74)
Heart rate (beats/min) 70 10 70 11
Systolic BP (mm Hg) 110 12 119 12
Diastolic BP (mm Hg) 68 9 72 8
NYHA functional class 3.0 0.8 2.7 0.5
QRS duration (ms) 163 28 167 31
Ischemic etiology (%) 11 (46) 13 (28)
LVIDd (cm) 7.74 0.90 7.56 0.87
EDVI (ml/m2) 161 47 133 37
ESVI (ml/m2) 120 38 99 34
Ejection fraction 25 6 26 6
Sphericity index 0.68 0.23 0.58 0.23
Delta EF after CRT 5.8 9.5 10.7 8.8
IntraVD by TDI (ms) 73 33 80 26
InterVD by TDI (ms) 83 52 81 47
SumVD (ms) 156 79 161 67
LWPSC (ms) 64 74 73 95
CRT  cardiac resynchronization therapy; LVIDd  left ventricular diameter a
abbreviations as in Table 1.to
47) p Value
0.145
0.526
0.893
0.001
0.039
0.090
0.217
0.558
0.382
0.004
0.015
0.974
0.013
0.022
0.252
0.514
0.687
0.412
t end diastole; otherric approach that focused on criteria combination
s
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1074significantly decreased the rate of false-positive
results. Thus, combining various echocardiographic
parameters might be a better approach for predict-
ing response to CRT; physicians should integrate
more than just evidence of dyssynchrony in their
management algorithm, taking into account degree
of LV remodeling as well as clinical factors, to
predict improvement of function.
Finally, although patients with ischemic heart
disease tend to have a lower probability of response
to CRT (32), we found only a trend toward a less
beneficial effect of CRT in patients with ischemic
versus nonischemic etiology of HF, both in terms of
increase in EF (7  9% vs. 10  9%, p  NS) and
in terms of events at follow-up (50% vs. 35%, p 
0.191). However, the relatively low prevalence of
patients with ischemic disease in the present study
might have contributed to reduce the statistical
power.
Study limitations. This is a nonrandomized study;
sample size is relatively small, due to stringent
selection criteria. Furthermore, 4 patients died be-
fore echocardiographic follow-up, and 6 were lost
to follow-up, which could be important with a small
sample size. The LV volumes were not assessed by
magnetic resonance or 3-dimensional echocardiog-
raphy, and this might have introduced errors in the
estimation of LV volumes. All patients had me-
chanical dyssynchrony; because this is not a man-
datory requisite by current clinical guidelines,
whether similar results can be obtained in patients
without mechanical dyssynchrony remains to be
demonstrated. Although concordance between LV
lead position and LV segment with maximal me-
chanical delay before CRT resulted in significantly
greater effectiveness of CRT in some studies (33),
Figure 4. Extent of Remodeling and Cardiac Events After CRT
(A) Incidence of cardiac events increased with increasing tertiles of
highest tertile of baseline ESVI. Abbreviation as in Figure 2.we did not assess optimal lead position at the time Pof implant, and only 68% of patients of our popu-
lation received the LV lead in a posterolateral vein.
However, significant improvement in cardiac func-
tion and exercise capacity has been shown, regard-
less of LV stimulation site, either considered singly
or grouped as lateral versus septal sites (34). Fur-
thermore, in the MADIT-CRT (Multicenter Au-
tomatic Defibrillator Implantation Trial—Cardiac
Resynchronization Therapy) trial the extent of
CRT benefit in term of decreased risk for HF/death
was similar for leads in the anterior, lateral, or
posterior position (35). Finally, it is also possible
that our echocardiographic follow-up was not suf-
ficiently long to catch further improvement in LV
function.
C O N C L U S I O N S
This study demonstrates that, in a HF population
with severely reduced EF and evidence of both
electrical and mechanical dyssynchrony, measures
of LV remodeling might have incremental prognos-
tic value over dyssynchrony indexes alone in pre-
dicting response to CRT. Despite the presence of
intraVD, patients with more dilated LV enjoy no or
limited benefit after implant. A multiparametric
echocardiographic strategy based on the combina-
tion of dyssynchrony measures and assessment of
severity and pattern of baseline LV remodeling
might help refine identification of patients sched-
uled for CRT.
Reprint requests and correspondence: Dr. Giuseppe Ambro-
io, Cardiologia e Fisiopatologia Cardiovascolare, Ospedale
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